Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 7 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 11491231

    Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials

    Northwestern University · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted

  2. US 11466071

    HLA class I-restricted t cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  3. US 11458136

    Antiviral prodrugs and formulations thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  4. US 11453667

    Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor

    Medshine Discovery Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  5. US 11452717

    Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  6. US 11453683

    KRas G12D inhibitors

    Mirati Therapeutics, Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  7. US 11447753

    Non-neuroinvasive viruses and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  8. US 11445997

    Ultrasound imaging of biomarker sensitive hydrogels

    SENTIOMED, INC. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  9. US 11446323

    Compositions and methods for the treatment of fibrotic diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  10. US 11407997

    Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders

    CRISPR THERAPEUTICS AG · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  11. US 11400150

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  12. US 11389550

    Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound

    NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  13. US 11389544

    Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  14. US 11370769

    TRPC5 inhibitors and methods of using same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  15. US 11358940

    K-Ras modulators

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  16. US 11351153

    Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  17. US 11344605

    Therapeutic use of inhibitors of t cell activation or stimulation

    HUMANITAS MIRASOLE S.P.A. · Granted May 31, 2022 · Expires May 26, 2042

    granted

  18. US 11345653

    Compositions and methods for reactivating cholinesterases

    The Government of the United States, as represented by the Secretary of the Army · Granted May 31, 2022 · Expires May 26, 2042

    granted

  19. US 11339378

    Non-neuroinvasive viruses and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 24, 2022 · Expires May 19, 2042

    granted

  20. US 11338037

    Ultrastable antibody ionic liquids

    United States of America as represented by the Secretary of the Air Force · Granted May 24, 2022 · Expires May 19, 2042

    granted

  21. US 11318224

    Nanofiber structures and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  22. US 11311545

    Compositions and methods for the delivery of therapeutics

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  23. US 11311547

    Antiviral prodrugs and nanoformulations thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  24. US 11312962

    Modulators of diacyglycerol acyltransferase 2 (DGAT2)

    Ionis Pharmaceuticals, Inc. · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.